Nu Skin Enterprises Inc (NUS) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket
 


Nu Skin Enterprises Inc   (NYSE: NUS)


Nu Skin Enterprises Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Nu Skin Enterprises Inc's ROI in the second quarter of 2026?
Nu Skin Enterprises Inc recorded a cumulative net loss of $-216 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -20.15%.

Within the Retail sector 16 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 1499, from total ROI ranking in the first quarter of 2026 at 1570.

Definition and Formula of Return on Investment



Return On Investment (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -8.72 % -4.83 % -10.21 % -15.49 % -15.92 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 865 1,120 1,142 1,170 1,160
Return On Investment (TTM) -20.15 % 4.75 % 13.92 % 9.46 % 8.57 %
NUS's Overall Ranking # 1499 # 1570 # 171 # 367 # 458
Seq. Investment Change TTM -6.42 % -0.25 % -0.66 % -1.56 % -2.44 %
Seq. Net Income Change TTM - -65.97 % 46.16 % 8.7 % -
Net Income (TTM) in Millions -216 55 160 110 101




Return On Investment NUS's Ranking
Within: No.
Industry # 0
Sector # 17
Overall # 1499

Return On Investment Statistics
High Average Low
36.5 %
10.52 %
-10.71 %
(Mar 31 2014)   (Jun 30 2024)







Financial Statements
Nu Skin Enterprises Inc's II. Quarter Investments $ 865 Millions NUS's Balance sheet
Nu Skin Enterprises Inc's II. Quarter Income $ -250 Millions Quarterly NUS's Income Statement
NUS's Income by Division See NUS's Income by Division


NUS Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 1,142 1,172 1,478 1,462 1,377
Y / Y Investment Growth -2.62 % -20.66 % 1.09 % 6.17 % -2.65 %
Net Income in Millions 160 -147 9 105 147
Y / Y Net Income Growth - - -91.8 % -28.85 % -23.04 %
Annual Return On Investment 14.03 % -12.5 % 0.58 % 7.17 % 10.7 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 14.03 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Pharmacy Services & Retail Drugstore Industry Roi Trends and Statistics
Retail Sector Return On Investment Statistics
Roi Trends for overall market
NUS's Roi Ratio versus Pharmacy Services & Retail Drugstore Industry, Retail Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NUS's Competitors
Subscribers only: Roi for Nu Skin Enterprises Inc's Suppliers
Subscribers only: Return On Investment for NUS's Customers

Other Ratios
NUS's Roa NUS's Inventory Turnover Ratio NUS's Growth Rates NUS's Dividend Statistics
NUS's Profitability Ratios NUS's Asset Turnover Ratio NUS's Dividend Growth
NUS's Roe NUS's Valuation Ratios NUS's Financial Strength Ratios NUS's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Retail Sector ROI


Date modified: 2026-09-12T06:18:48+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.